Pay in 4 interest-free payments of $31.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
(2002) Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease
Interestingly
p13) translocation in a malignant T cell lymphoma
082 Purity: 95% Description
Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF
Mouse Control Antibody IgG2a Wildtype Fc Amount:2 mg (2002) Costimulatory molecule-targeted antibody therapyA CDR silenced mouse IgG2a antibody with a wildtype Fc domain, PZMU001 binds to mouse FcRI and FcRIV with high affinity, to FcRIIb and FcRIII with lower affinity, and can be recycled through binding to FcRn. Interacting protein(s): Fc Receptors Related products: Other Biotin Z MABs For orders over 10 mg please inquire here. An antibody does not bind to antigen the best control antibody commercially available. For the control arm of an antibody study,
US$ 2723.65
US$ 891.00
US$ 1198.00
